PATENT CLAIM ANALYSIS

Application Number: 15746964
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-11
Patent Classification: ["514", "168000"]

Abstract:
The invention relates to new compounds with low cytotoxicity for blocking the ubiquitination-proteasome system in diseases. Accordingly, these compounds can be used in treatment of disorders including, but not limited to, cancers, neurodegenerative diseases, inflammatory disorders, autoimmune disorders and metabolic disorders.

Claim (Index 23):
The method of  claim 22 , wherein the metabolic disorder is diabetes, high blood pressure, cholesterol, elevated triglyceride level, impaired fasting glucose or insulin resistance.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 86.0
- Lexical Diversity: 1.36111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12555018', '12309459', '14790978', '13906626', '14592801']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8033774689495151
- 35 USC 102 Novelty (BERT): 0.5229322368577294
- Combined Prediction Score: 0.7753329457403365
- Mean Citation Score: 266.204172
- Max Citation Score: 272.8594
- Similarity Product: 145.3544311037064

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test